New transplant approach aims to tame deadly cancers

NCT ID NCT01804634

First seen Mar 22, 2026 · Last updated May 17, 2026 · Updated 10 times

Summary

This study tests a bone marrow transplant from a half-matched family donor for people with high-risk solid tumors that have come back or spread. Doctors use milder chemotherapy and shorter immune-suppressing drugs to make the treatment safer. The goal is to see if this approach can control the cancer while reducing serious side effects like graft-versus-host disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY AND/OR RELAPSED METASTATIC SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Albert Einstein College of Medicine, Children's Hospital at Montefiore

    RECRUITING

    The Bronx, New York, 10467, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • New York Medical Center/ Maria Fareri Children's Hospital

    RECRUITING

    Valhalla, New York, 10595, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    RECRUITING

    Baltimore, Maryland, 21231, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.